IMPACT OF THE RSV F NANOPARTICLE VACCINE DURING PREGNANCY ON THE BURDEN OF RESPIRATORY TRACT SYMPTOMATOLOGY IN CHILDREN UP TO 24 MONTHS OF AGE. FOLLOW‐UP OF A RANDOMIZED CONTROLLED TRIAL